TCL Archive In Sign-Off Of Two Orphan Drugs, ODAC Leaves Efficacy Interpretation To Docs November 27, 1998
TCL Archive User Fees Proposed For FDA Oversight Services; Industry Groups Call It “Tax On Innovations” January 20, 1989
TCL Archive Retraction Based On Data Given To Duke Last November, But Apparently Disregarded October 29, 2010